Jaclyn P. Lyman

1.1k total citations
11 papers, 313 citations indexed

About

Jaclyn P. Lyman is a scholar working on Oncology, Cancer Research and Neurology. According to data from OpenAlex, Jaclyn P. Lyman has authored 11 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Cancer Research and 2 papers in Neurology. Recurrent topics in Jaclyn P. Lyman's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (6 papers) and Breast Cancer Treatment Studies (3 papers). Jaclyn P. Lyman is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (6 papers) and Breast Cancer Treatment Studies (3 papers). Jaclyn P. Lyman collaborates with scholars based in United States and Italy. Jaclyn P. Lyman's co-authors include Judy C. Boughey, Kandace P. McGuire, Tari A. King, Marina De Brot, Antonio C. Wolff, Kala Visvanathan, Stacie C. Jeter, Lisa A. Carey, Wei Wen Teo and Mary Jo Fackler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Cancer Immunology Immunotherapy.

In The Last Decade

Jaclyn P. Lyman

10 papers receiving 309 citations

Peers

Countries citing papers authored by Jaclyn P. Lyman

Since Specialization

Citations

This map shows the geographic impact of Jaclyn P. Lyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaclyn P. Lyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaclyn P. Lyman more than expected).

Fields of papers citing papers by Jaclyn P. Lyman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaclyn P. Lyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaclyn P. Lyman. The network helps show where Jaclyn P. Lyman may publish in the future.

Co-authorship network of co-authors of Jaclyn P. Lyman

This figure shows the co-authorship network connecting the top 25 collaborators of Jaclyn P. Lyman. A scholar is included among the top collaborators of Jaclyn P. Lyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaclyn P. Lyman. Jaclyn P. Lyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Circulating KRAS variant-specific shedding and association with survival in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) receiving chemoimmunotherapy. 2022 ·Journal of Clinical Oncology ·Jacob E. Till, Lee McDaniel, Shannon M. Pfeiffer, Deena M. Maurer, Jia Xin Yu, Christine N. Spencer, Jaclyn P. Lyman, Christopher R. Cabanski, Diane M. Da Silva, Charles W. Abbott, Sean Michael Boyle, Osama E. Rahma, George A. Fisher, Andrew H. Ko, Zev A. Wainberg, Robert A. Wolff, Eileen M. O’Reilly, Mark H. O’Hara, Robert H. Vonderheide, Erica L. Carpenter	1
2	Feasibility and utility of synthetic control arms derived from real-world data to support clinical development. 2022 ·Journal of Clinical Oncology ·Jaclyn P. Lyman, Abigail Doucette, Binbin Zheng-Lin, Christopher R. Cabanski, Molly Maloy, Nicholas Bayless, Jingying Xu, William Smith, Joyson Karakunnel, Justin Fairchild, Ramy Ibrahim, Eileen M. O’Reilly, Robert H. Vonderheide, Peter Gabriel	3
3	Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy. 2021 ·Journal of Clinical Oncology ·Jacob E. Till, (unknown), Neha Bhagwat, Taylor A. Black, (unknown), Stephanie S. Yee, Pier Federico Gherardini, (unknown), Cheryl Selinsky, Jaclyn P. Lyman, Theresa LaVallee, George A. Fisher, Osama E. Rahma, (unknown), Zev A. Wainberg, Robert A. Wolff, Eileen M. O’Reilly, Robert H. Vonderheide, Mark H. O’Hara, Erica L. Carpenter	1
4	Gemcitabine (Gem) and nab-paclitaxel (NP) ± nivolumab (nivo) ± CD40 agonistic monoclonal antibody APX005M (sotigalimab), in patients (Pts) with untreated metastatic pancreatic adenocarcinoma (mPDAC): Phase (Ph) 2 final results. 2021 ·Journal of Clinical Oncology ·Mark H. O’Hara, Eileen M. O’Reilly, Robert A. Wolff, Zev A. Wainberg, Andrew H. Ko, Osama E. Rahma, George A. Fisher, Jaclyn P. Lyman, Christopher R. Cabanski, Joyson Karakunnel, Pier Federico Gherardini, (unknown), Samantha Bucktrout, Elizabeth Christopher, Rosemarie Mick, Richard Chen, Ovidiu C. Trifan, Lisa Salvador, Jill O’Donnell-Tormey, Robert H. Vonderheide	16
5	Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients 2019 ·Clinical Trials ·Mark H. O’Hara, Eileen M. O’Reilly, Rosemarie Mick, Gauri R. Varadhachary, Zev A. Wainberg, Andrew H. Ko, George A. Fisher, Osama E. Rahma, Jaclyn P. Lyman, Christopher R. Cabanski, Erica L. Carpenter, (unknown), Pier Federico Gherardini, Lacey Kitch, Cheryl Selinsky, Theresa LaVallee, Ovid Trifan, Ute Dugan, Vanessa M. Hubbard-Lucey, Robert H. Vonderheide	13
6	Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients 2019 ·Cancer Research ·Mark H. O’Hara, Eileen M. O’Reilly, Rosemarie Mick, Gauri R. Varadhachary, Zev A. Wainberg, Andrew H. Ko, George A. Fisher, Osama E. Rahma, Jaclyn P. Lyman, Christopher R. Cabanski, Erica L. Carpenter, (unknown), Pier Federico Gherardini, (unknown), Cheryl Selinsky, Theresa LaVallee, Ovid Trifan, Ute Dugan, Vanessa M. Hubbard-Lucey, Robert H. Vonderheide	55
7	The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology 2018 ·Cancer Immunology Immunotherapy ·Anna Maria Di Giacomo, (unknown), (unknown), Ramy Ibrahim, Jaclyn P. Lyman, Pier Giorgio Natali, Michele Maio	0
8	A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013). 2016 ·Journal of Clinical Oncology ·Tari A. King, Jaclyn P. Lyman, Mithat Gönen, (unknown), Eun-Sil Shelley Hwang, Hope S. Rugo, Minetta C. Liu, Judy C. Boughey, Lisa K. Jacobs, Kandace P. McGuire, Anna Maria Storniolo, Claudine Isaacs, Ingrid M. Meszoely, Catherine Van Poznak, Gildy V. Babiera, Larry Norton, Monica Morrow, Antonio C. Wolff, Eric P. Winer, Clifford A. Hudis	42
9	Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013 2016 ·Journal of Clinical Oncology ·Tari A. King, Jaclyn P. Lyman, Mithat Gönen, (unknown), Marina De Brot, (unknown), Amy P. Sing, E. Shelley Hwang, Michael Alvarado, Minetta C. Liu, Judy C. Boughey, Kandace P. McGuire, Catherine Van Poznak, Lisa K. Jacobs, Ingrid M. Meszoely, Helen Krontiras, Gildy V. Babiera, Larry Norton, Monica Morrow, Clifford A. Hudis	61
10	Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer 2014 ·Cancer Research ·Mary Jo Fackler, Zoila A. Lopez‐Bujanda, Christopher B. Umbricht, Wei Wen Teo, Soonweng Cho, Zhe Zhang, Kala Visvanathan, Stacie C. Jeter, Pedram Argani, Chenguang Wang, Jaclyn P. Lyman, Marina De Brot, James N. Ingle, Judy C. Boughey, Kandace P. McGuire, Tari A. King, Lisa A. Carey, Leslie Cope, Antonio C. Wolff, Saraswati Sukumar	118
11	Prognostic impact of the 21-gene recurrence score in patients presenting with stage IV breast cancer. 2013 ·Journal of Clinical Oncology ·Tari A. King, Jaclyn P. Lyman, Mithat Gönen, (unknown), Marina De Brot, (unknown), Amy P. Sing, Eun-Sil Shelley Hwang, Michael Alvarado, Minetta C. Liu, Judy C. Boughey, Kandace P. McGuire, Catherine Van Poznak, Lisa K. Jacobs, Ingrid M. Meszoely, Helen Krontiras, Gildy V. Babiera, Larry Norton, Monica Morrow, Clifford A. Hudis	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact